Last reviewed · How we verify
anti-Mesothelin Car NK Cells — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
anti-Mesothelin Car NK Cells (anti-Mesothelin Car NK Cells) — Allife Medical Science and Technology Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| anti-Mesothelin Car NK Cells TARGET | anti-Mesothelin Car NK Cells | Allife Medical Science and Technology Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- anti-Mesothelin Car NK Cells CI watch — RSS
- anti-Mesothelin Car NK Cells CI watch — Atom
- anti-Mesothelin Car NK Cells CI watch — JSON
- anti-Mesothelin Car NK Cells alone — RSS
Cite this brief
Drug Landscape (2026). anti-Mesothelin Car NK Cells — Competitive Intelligence Brief. https://druglandscape.com/ci/anti-mesothelin-car-nk-cells. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab